Chem. J. Chinese Universities ›› 2004, Vol. 25 ›› Issue (10): 1885.

• Articles • Previous Articles     Next Articles

UV Photodissociation Dynamics of n-Alkyl Bromide

ZHU Rong-Shu, TANG Bi-Feng, JI Lei, TANG Ying, ZHANG Song, WANG Yan-Mei, ZHANG Bing   

  1. State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Institute of Physics and Mathematics, Chinese Acadmemy of Sciences, Wuhan 430071, China
  • Received:2003-12-08 Online:2004-10-24 Published:2004-10-24

Abstract: With the deep development of environmental investigation, some alkyl bromides of higher homolog(e.g., C2H5Br, n-C3H7Br, n-C4H9Br) in the lower stratosphere have attracted a little attention in recent years. But the photodissociation dynamics of them have not been studied. In this work, we reported the photodissociation dynamics of n-alkyl bromides R_Br(R=n-alkyl radical)(C2H5Br, n-C3H7Br, n-C4H9Br) at 234 and267nm using resonace-enhanced multiphoton ionization (REMPI) with time-flight mass spectrometry(TOF-MS) and the goal was to study the dependencies of the relative quantum yields of φ(Br*) and φ(Br) on photon energy and the molecular complexity. The measured values of the φ(Br*) were found to be φ(Br*)234nm=0.286 and φ(Br*)267nm=0.338 for C2H5Br, φ(Br*)234nm=0.356 and φ(Br*)267nm=0.294 for n-C3H7Br, φ(Br*)234nm=0.428 and φ(Br*)267nm=0.341 for n-C4H9Br.The results of φ(Br*) clearly showed an increasing tendency with the increase of molecular complexity at 234 nm(C2H5Br<n-C3H7Br<n-C4H9Br), while the φ(Br*) at 267 nm showed a relatively little change. Simultaneously, the φ(Br*) was found to be strongly dependent on the excitation energy except for C2H5Br and showed an increasing tendency with the increase of photon energy[φ(Br*)267nm< φ(Br*)234nm]. This increasing tendency of φ(Br*) with the increase of excitation energy was in good agreement with the results observed in photodissociation of n-alkyl iodides.

Key words: n-Alkyl bromide, REMPI-TOFMS, Photodissociation dynamics, Branching ratio

CLC Number: 

TrendMD: